Pro-CRISPR PcrIIC1-associated Cas9 system for enhanced bacterial immunity

• 成果类型: Article
• 署名作者: Zhang, Shouyue; Sun, Ao; Qian, Jing-Mei; Lin, Shuo; Xing, Wenjing; Yang, Yun; Zhu, Han-Zhou; Zhou, Xin-Yi; Guo, Yan-Shuo; Liu, Yun; Meng, Yu; Jin, Shu-Lin; Song, Wenhao; Li, Cheng-Ping; Li, Zhaofu; Jin, Shuai; Wang, Jian-Hua; Dong, Meng-Qiu; Gao, Caixia; Chen, Chunlai; Bai, Yang; Liu, Jun-Jie Gogo
• 署名单位: Tsinghua University; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; National Institute of Biological Sciences, Beijing; Tsinghua University; Peking University
• 刊物名称: Nature
• ISSN/ISSBN: 0028-5161
• DOI: 10.1038/s41586-024-07486-x
• 发表日期: 2024-06-13
• 页码: 484-+
• 关键词: read

摘要

The CRISPR system is an adaptive immune system found in prokaryotes that defends host cells against the invasion of foreign DNA(1). As part of the ongoing struggle between phages and the bacterial immune system, the CRISPR system has evolved into various types, each with distinct functionalities(2). Type II Cas9 is the most extensively studied of these systems and has diverse subtypes. It remains uncertain whether members of this family can evolve additional mechanisms to counter viral invasions(3,4). Here we identify 2,062 complete Cas9 loci, predict the structures of their associated proteins and reveal three structural growth trajectories for type II-C Cas9. We found that novel associated genes (NAGs) tended to be present within the loci of larger II-C Cas9s. Further investigation revealed that CbCas9 from Chryseobacterium species contains a novel beta-REC2 domain, and forms a heterotetrameric complex with an NAG-encoded CRISPR-Cas-system-promoting (pro-CRISPR) protein of II-C Cas9 (PcrIIC1). The CbCas9-PcrIIC1 complex exhibits enhanced DNA binding and cleavage activity, broader compatibility for protospacer adjacent motif sequences, increased tolerance for mismatches and improved anti-phage immunity, compared with stand-alone CbCas9. Overall, our work sheds light on the diversity and 'growth evolutionary' trajectories of II-C Cas9 proteins at the structural level, and identifies many NAGs-such as PcrIIC1, which serves as a pro-CRISPR factor to enhance CRISPR-mediated immunity.